Tianan Pharmaceutical Co Stock Revenue
| TNPH Stock | USD 0.01 0.00 0.00% |
Tianan Pharmaceutical Co fundamentals help investors to digest information that contributes to Tianan Pharmaceutical's financial success or failures. It also enables traders to predict the movement of Tianan Pink Sheet. The fundamental analysis module provides a way to measure Tianan Pharmaceutical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Tianan Pharmaceutical pink sheet.
Tianan |
Tianan Pharmaceutical Co Company Revenue Analysis
Tianan Pharmaceutical's Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Current Tianan Pharmaceutical Revenue | 10.65 M |
Most of Tianan Pharmaceutical's fundamental indicators, such as Revenue, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Tianan Pharmaceutical Co is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
| Competition |
Based on the latest financial disclosure, Tianan Pharmaceutical Co reported 10.65 M of revenue. This is 99.86% lower than that of the Healthcare sector and significantly higher than that of the Drug Manufacturers—Specialty & Generic industry. The revenue for all United States stocks is 99.89% higher than that of the company.
Tianan Revenue Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Tianan Pharmaceutical's direct or indirect competition against its Revenue to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Tianan Pharmaceutical could also be used in its relative valuation, which is a method of valuing Tianan Pharmaceutical by comparing valuation metrics of similar companies.Tianan Pharmaceutical is currently under evaluation in revenue category among its peers.
Tianan Fundamentals
| Return On Equity | 0.25 | |||
| Return On Asset | 0.18 | |||
| Profit Margin | 0.30 % | |||
| Operating Margin | 0.36 % | |||
| Current Valuation | 979.64 K | |||
| Price To Earning | 0.15 X | |||
| Price To Book | 1.20 X | |||
| Price To Sales | 1.62 X | |||
| Revenue | 10.65 M | |||
| Gross Profit | 7.3 M | |||
| EBITDA | 4.31 M | |||
| Net Income | 3.14 M | |||
| Cash And Equivalents | 8.23 M | |||
| Cash Per Share | 0.59 X | |||
| Current Ratio | 14.23 X | |||
| Book Value Per Share | 1.03 X | |||
| Cash Flow From Operations | 2.56 M | |||
| Earnings Per Share | 0.01 X | |||
| Number Of Employees | 16 | |||
| Beta | 0.86 | |||
| Market Capitalization | 17.29 M | |||
| Total Asset | 15.38 M | |||
| Retained Earnings | 4.96 M | |||
| Working Capital | 11.29 M | |||
| Current Asset | 12.14 M | |||
| Current Liabilities | 853 K | |||
| Net Asset | 15.38 M |
About Tianan Pharmaceutical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Tianan Pharmaceutical Co's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Tianan Pharmaceutical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Tianan Pharmaceutical Co based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in Tianan Pink Sheet
Tianan Pharmaceutical financial ratios help investors to determine whether Tianan Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Tianan with respect to the benefits of owning Tianan Pharmaceutical security.